This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on March 22, 2022 and assigned serial number 90448135 by the TTAB.

Plaintiff:
Sanofi represented by RICHARD LEHV of FROSS ZELNICK LEHRMAN & ZISSU, P.C..

Defendant:
Biohaven Therapeutics Ltd. represented by MONICA RIVA TALLEY of .
Trademark Information: GLYXYN – US Trademark Serial Number 90448135
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
March 22, 2022 – FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE
March 22, 2022 – EXT GRANTED
June 22, 2022 – FINAL 60-DAY REQUEST TO EXT TIME TO OPPOSE
June 22, 2022 – EXT GRANTED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.